ArticleJournal of biomedical optics2025
Deep learning segmentation of periarterial and perivenous capillary-free zones in optical coherence tomography angiography.
Article in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- OCTA-ReVABiomedical optics express · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Significance: Automated segmentation of periarterial and perivenous capillary-free zones (CFZs) in optical coherence tomography angiography (OCTA) can significantly improve early detection and monitoring of diabetic retinopathy (DR), a leading cause of vision impairment, by identifying subtle microvascular changes. Aim: We aimed to develop and evaluate deep learning models, including convolutional neural networks (CNNs) and vision transformers (ViTs), for precise segmentation of periarterial and perivenous CFZs. Quantitative features derived from the segmented CFZs were assessed as potential biomarkers for DR. Approach: OCTA images from healthy controls, patients with diabetes but no DR (NoDR), and those with mild DR were utilized. Automated CFZ maps were generated using deep learning models such as UNet, UNet++, TransUNet, and Segformer. Quantitative features, including CFZ ratios, counts, and mean sizes, were analyzed to characterize disease progression. Results: UNet++ with EfficientNet-b7 achieved the best performance, with a mean intersection over union of 86.48% and a Dice coefficient of 89.87%. Quantitative analyses revealed significant differences in CFZ metrics between the control, NoDR, and mild DR groups, demonstrating their potential as sensitive biomarkers for early DR detection and monitoring. Conclusions: The study underscores the efficacy of deep learning models in automating CFZ segmentation and introduces quantitative features as biomarkers for DR. These findings support further exploration of CFZ analysis in retinal disease diagnostics and therapeutic monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.